Health Care | Member of GICS Eleven - The GATE to get reliable sector Information

Key Market Indicator:

F&G: 54

25.463,31 NASDAQ · 49.317,50 DOW · 6.902,34 S&P · 4.939,32 Gold · 64,19 BRENT

One Community. One Spirit. N#1 Broker.
all asset classes · all possibilities

<p>One Community. One Spirit. <strong>N#1 <span style="color:hsl(0,80%,42%);">Broker.</strong></span><br><span class="text-tiny" style="color:hsl(0, 0%, 60%);">all asset classes · all possibilities</span></p>

Switch View

Sektor SSR

Sektor Hedge

Hedge

Int

Hedge the Peak | Protect your Profits

14.05.2024

ISIN: DK0060448595

Coloplast A/S

COLO B

LISTED

CPH

Coloplast expands its Luja™ portfolio with next generation catheter for women

Artikel

News Preview

The female intermittent catheter enables complete bladder emptying in one free flow1, aiming to reduce the risk of urinary tract infections2....

Themefolio

Profiler

Peergroup

OMXCOP:COLO_B

*TF

Coloplast A/S develops, manufactures, and markets medical products. The company is engaged in the development, marketing and sale of intimate healthcare products and services, targeting people with diseases of private and personal nature. Its operations are structured into four business areas: Ostom...

... ...More Info

Where to trade?

26.000 tradable Securities, ETFs ...., Inform here

Field	Value
Name	Coloplast
Ticker	COLOb.CO
ISIN	DK0060448595
WKN	A1KAGC
SYMBOL	COLO B
CUSIP	K16018192
SEDOL	B8FMRX8
GICS	Health Care
FIGI	BBG000BLV8Z0
TV:ID	OMXCOP:COLO_B
IPO	23.01.2026
PEER	EQTY
ID	9701

Interested in more information from
Coloplast

14.05.2024

ISIN: CH0012549785

Sonova Holding AG

SOON

LISTED

SIX

Sonova mit verbesserter Wachstumsdynamik nach Beschleunigung in der zweiten Hälfte

Artikel

News Preview

Ad hoc-Mitteilung gemäss Art. 53 KR Stäfa (Schweiz), 14. Mai 2024 – Sonova Holding AG, ein führender Anbieter von Hörlösungen, gibt heute das Ergebnis für das Geschäftsjahr 2023/24 bekannt. Erwartungsgemäss verbesserte sich die Umsatz- und Gewinnentwicklung in der zweiten Jahreshälfte. Die Gruppe erzielte einen Umsatz von CHF 3'626,9 Mio., ein Plus......

Themefolio

Profiler

Peergroup

SIX:SOON

*TF

Sonova Holding AG designs, develops, manufactures, and distributes hearing care solutions for adults and children. It operates through two segments, Hearing Instruments and Cochlear Implants segments. The company offers wireless communication products; rechargeable hearing aids; wireless headsets, s...

... ...More Info

Where to trade?

26.000 tradable Securities, ETFs ...., Inform here

Field	Value
Name	Sonova
Ticker	SOON.S
ISIN	CH0012549785
WKN	893484
SYMBOL	SOON
CUSIP	H8024W106
SEDOL	7156036
GICS	Health Care
FIGI	BBG000J03DM2
TV:ID	SIX:SOON
IPO	01.04.2000
PEER	EQTY
ID	8641

Interested in more information from
Sonova

14.05.2024

ISIN: CH0012549785

Sonova Holding AG

SOON

LISTED

SIX

Sonova ends year on improving trajectory after growth picks up in second half

Artikel

News Preview

Ad hoc announcement pursuant to Art. 53 LR Stäfa (Switzerland), May 14, 2024 – Sonova Holding AG, a leading provider of hearing care solutions, today reports its results for the 2023/24 financial year. As expected, both sales and earnings growth picked up in the second half. The Group achieved sales of CHF 3,626.9 million, up 3.2% in local currenci......

Themefolio

Profiler

Peergroup

SIX:SOON

*TF

... ...More Info

Where to trade?

26.000 tradable Securities, ETFs ...., Inform here

Field	Value
Name	Sonova
Ticker	SOON.S
ISIN	CH0012549785
WKN	893484
SYMBOL	SOON
CUSIP	H8024W106
SEDOL	7156036
GICS	Health Care
FIGI	BBG000J03DM2
TV:ID	SIX:SOON
IPO	01.04.2000
PEER	EQTY
ID	8641

Interested in more information from
Sonova

Worth to know

20.10.2025

Short Selling Radar

USA, Europe, Asia

Track Short Selling Activities worldwide

More Info

Knowing what matters

Leerverkaufsstatistiken, Hedge-Fund Aktivitäten und viele weitere nutzerwertige Informationen benutzerfreundlich aufbereitet

13.05.2024

ISIN: BE0003874915

Fagron NV

FAGR

LISTED

EURONEXT

Fagron shareholders approve all voting items at AGM and EGM

Artikel

News Preview

Regulated informationNazareth (Belgium)/Rotterdam (The Netherlands), 13 May 2024 – 7PM CET...

Themefolio

Profiler

Peergroup

EURONEXT:FAGR

*TF

Fagron NV, a pharmaceutical compounding company, provides personalized medicine care to hospitals, pharmacies, clinics, and patients. The company also innovates concepts, vehicles, and formulations for pharmaceutical compounding. In addition, it supplies raw materials, utensils and equipment, semi-f...

... ...More Info

Where to trade?

26.000 tradable Securities, ETFs ...., Inform here

Field	Value
Name	Fagron N.V.
Ticker	FAGRO.BR
ISIN	BE0003874915
WKN	A0M103
SYMBOL	FAGR
CUSIP	B3921R108
SEDOL	B281L72
GICS	Health Care
FIGI	BBG000BY0K25
TV:ID	EURONEXT:FAGR
IPO	05.10.2007
PEER	EQTY
ID	2395

Sponsor

SOMETHING BIG WILL HAPPEN

Um den Chart aufzurufen, Symbol unten rechts benutzen

Hedge · Leverage · Fractionals

Interested in more information from
Fagron N.V.

Swarmalpha i/o · The Event Futures Prediction X

20.10.2025

13.05.2024

ISIN: DE0007165607

Sartorius AG

SRT

LISTED

XETRA

Sartorius collaborates with Sanofi to commercialize end-to-end platform for downstream process intensification

Artikel

News Preview

Göttingen, Germany | May 13, 2024 Sartorius collaborates with Sanofi to commercialize end-to-end platform for downstream process intensification Sartorius selected as preferred partner for development and commercialization of integrated and continuous biomanufacturing (ICB) platform Modular platform will combine highest flexibility with stand......

Themefolio

Profiler

Peergroup

XETR:SRT

*TF

Sartorius Aktiengesellschaft provides bioprocess solutions and lab products and services worldwide. The company offers biosensors and kits, compliance tools, systems software, label-free detection systems, and SPR systems; live-cell analysis systems, flow cytometry platform, and cell analysis reagen...

... ...More Info

Where to trade?

26.000 tradable Securities, ETFs ...., Inform here

Field	Value
Name	Sartorius
Ticker	SATG.DE
ISIN	DE0007165607
WKN	716560
SYMBOL	SRT
CUSIP	D6705R101
SEDOL	5843307
GICS	Health Care
FIGI	BBG000BFKDJ2
TV:ID	XETR:SRT
IPO	26.11.2010
PEER	EQTY
ID	9300

Interested in more information from
Sartorius

13.05.2024

ISIN: DE0007165607

Sartorius AG

SRT

LISTED

XETRA

Sartorius kooperiert mit Sanofi bei Vermarktung von Technologie-Plattform für die Intensivierung von biopharmazeutischen Herstellungsprozessen

Artikel

News Preview

Göttingen, 13. Mai 2024 Sartorius kooperiert mit Sanofi bei Vermarktung von Technologie-Plattform für die Intensivierung von biopharmazeutischen Herstellungsprozessen Sartorius ist bevorzugter Partner für die Entwicklung und Kommerzialisierung einer Plattform für integrierte und kontinuierliche Bioprozesse (ICB) Modulare Plattform kombiniert h......

Themefolio

Profiler

Peergroup

XETR:SRT

*TF

... ...More Info

Where to trade?

26.000 tradable Securities, ETFs ...., Inform here

Field	Value
Name	Sartorius
Ticker	SATG.DE
ISIN	DE0007165607
WKN	716560
SYMBOL	SRT
CUSIP	D6705R101
SEDOL	5843307
GICS	Health Care
FIGI	BBG000BFKDJ2
TV:ID	XETR:SRT
IPO	26.11.2010
PEER	EQTY
ID	9300

Interested in more information from
Sartorius

13.05.2024

ISIN: US00507W2061

Actinium Pharmaceuticals Inc

ATNM

LISTED

XASE

Actinium Announces Multiple Abstracts Highlighting its Antibody Radiation Conjugates Iomab-B and Actimab-A and Novel Linker Technology for Solid Tumors Accepted for Presentation at the 2024 Society of Nuclear Medicine & Molecular Imaging Annual Meetin

Artikel

News Preview

- Iomab-B and Actimab-A are the only targeted radiotherapies in for acute myeloid leukemia addressing different parts of the patient journey - Improved survival demonstrated with both Iomab-B and Actimab-A in patients with high-risk acute myeloid leukemia including those with a TP53 mutation and prior venetoclax treatment - Nove...

Themefolio

Profiler

Peergroup

AMEX:ATNM

*TF

Actinium Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing therapies for bone marrow transplant (BMT) or a type of cellular therapy, and for other adoptive cell therapies. Its lead product candidate, I-131 apamistamab (Iomab-B) that is in a ...

... ...More Info

Where to trade?

26.000 tradable Securities, ETFs ...., Inform here

Field	Value
Name	Actinium Pharmaceuticals
Ticker	ATNM.A
ISIN	US00507W2061
WKN	A2QA48
SYMBOL	ATNM
CUSIP	00507W206
SEDOL	BLFH013
GICS	Health Care
FIGI	BBG000RQZ245
TV:ID	AMEX:ATNM
IPO	27.12.2012
PEER	Healthcare
ID	5789

Interested in more information from
Actinium Pharmaceuticals

13.05.2024

ISIN: DK0010272202

Genmab A/S

GMAB

LISTED

CPH

Transactions in Connection with Share Buy-back Program

Artikel

News Preview

Company Announcement...

Themefolio

Profiler

Peergroup

OMXCOP:GMAB

*TF

Genmab A/S develops antibody therapeutics for the treatment of cancer and other diseases primarily in Denmark. The company markets DARZALEX, a human monoclonal antibody for the treatment of patients with multiple myeloma (MM); teprotumumab for the treatment of thyroid eye disease; and Amivantamab fo...

... ...More Info

Where to trade?

26.000 tradable Securities, ETFs ...., Inform here

Field	Value
Name	Genmab
Ticker	GMAB.CO
ISIN	DK0010272202
WKN	565131
SYMBOL	GMAB
CUSIP	K3967W102
SEDOL	4595739
GICS	Health Care
FIGI	BBG000BKPC99
TV:ID	OMXCOP:GMAB
IPO	23.01.2026
PEER	EQTY
ID	9987

Interested in more information from
Genmab

13.05.2024

ISIN: DK0060055861

Chemometec A/S

CHEMM

LISTED

CPH

Notification of managers' transactions

Artikel

News Preview

ANNOUNCEMENT NO. 263...

Themefolio

Profiler

Peergroup

OMXCOP:CHEMM

*TF

ChemoMetec A/S engages in the development, production, and sale of analytical equipment for cell counting and analysis the United States, Canada, Europe, and internationally. The company offers its solutions in are areas of cell-based therapy, cancer, and stem cell research, development, and manufac...

... ...More Info

Where to trade?

26.000 tradable Securities, ETFs ...., Inform here

Field	Value
Name	ChemoMetec
Ticker	CHEMM.CO
ISIN	DK0060055861
WKN	A0MS80
SYMBOL	CHEMM
CUSIP	K18309102
SEDOL	B1KBGS9
GICS	Health Care
FIGI	BBG000R59D46
TV:ID	OMXCOP:CHEMM
IPO	23.01.2026
PEER	EQTY
ID	9665

Interested in more information from
ChemoMetec

13.05.2024

ISIN: US75629V1044

Recursion Pharmaceuticals Inc

RXRX

LISTED

NASDAQ

Recursion Announces Completion of NVIDIA-Powered BioHive-2, the Largest Supercomputer in Pharmaceutical Industry

Artikel

News Preview

BioHive-2, an NVIDIA DGX SuperPOD with NVIDIA DGX H100 systems, ranked #35 in the TOP500 list of the most powerful supercomputers in the world across all industries as of May 2024. BioHive-2, an NVIDIA DGX SuperPOD with NVIDIA DGX H100 systems, ranked #35 in the TOP500 list of the most powerful supercomputers in the world across all industries as o...

Themefolio

Profiler

Peergroup

NASDAQ:RXRX

*TF

Recursion Pharmaceuticals, Inc. operates as a clinical-stage biotechnology company, engages in the decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering to industrialize drug discovery. The company develops REC-994, which is in...

... ...More Info

Where to trade?

26.000 tradable Securities, ETFs ...., Inform here

Field	Value
Name	Recursion Pharmaceuticals
Ticker	RXRX.OQ
ISIN	US75629V1044
WKN	A3CM1C
SYMBOL	RXRX
CUSIP	75629V104
SEDOL	BM9FJ13
GICS	Health Care
FIGI	BBG00PQ4XJ45
TV:ID	NASDAQ:RXRX
IPO	16.04.2021
PEER	Healthcare
ID	4440

Interested in more information from
Recursion Pharmaceuticals

13.05.2024

ISIN: NL0012169213

Qiagen NV

QGEN

LISTED

NYSE

QIAGEN erhält FDA-Zulassung für syndromischen QIAstat-Dx-Test zur schnellen und präzisen Diagnose von Atemwegserkrankungen

Artikel

News Preview

QIAstat-Dx Respiratory Panel Plus ist für genaue Diagnose von Atemwegsinfektionen konzipiert und ermöglicht auch Erkennung von Ko-Infektionen // Panel liefert Ergebnisse in etwa einer Stunde bei weniger als einer Minute aktiver Arbeitszeit und bietet leicht ablesbare Cycle-Threshold (Ct)-Werte sowie Amplifikationskurven // QIAGEN arbeitet an der Er...

Themefolio

Profiler

Peergroup

NYSE:QGEN

*TF

Field	Value
Name	Qiagen
Ticker	QIA.DE
ISIN	NL0012169213
WKN	A2DKCH
SYMBOL	QGEN
CUSIP	N72482123
SEDOL	BYXS688
GICS	Health Care
FIGI	-
TV:ID	NYSE:QGEN
IPO	03.02.2001
PEER	Medical tech
ID	473

Interested in more information from
Qiagen

12.05.2024

ISIN: DK0060257814

Zealand Pharma A/S

ZEAL

LISTED

CPH

Transactions in Zealand Pharma shares and/or related securities by persons discharging managerial responsibilities and/or their closely associated persons

Artikel

News Preview

Company announcement – No. 25 / 2024...

Themefolio

Profiler

Peergroup

OMXCOP:ZEAL

*TF

Zealand Pharma A/S, a biotechnology company, engages in the discovery, development, and commercialization of peptide-based medicines in Denmark. It has a portfolio of medicines focusing on gastrointestinal and metabolic diseases, and other specialty disease areas with unmet medical needs. The compan...

... ...More Info

Where to trade?

26.000 tradable Securities, ETFs ...., Inform here

Field	Value
Name	Zealand Pharma
Ticker	ZELA.CO
ISIN	DK0060257814
WKN	A0YJW7
SYMBOL	ZEAL
CUSIP	K9898X127
SEDOL	B0SDJB4
GICS	Health Care
FIGI	BBG0018JWYS7
TV:ID	OMXCOP:ZEAL
IPO	05.05.2004
PEER	EQTY
ID	10966

Interested in more information from
Zealand Pharma

Advertisment

20.10.2025

10.05.2024

ISIN: US45783C2008

Instil Bio Inc

TIL

LISTED

NASDAQ

Instil Bio Reports First Quarter 2024 Financial Results and Provides Corporate Update

Artikel

News Preview

DALLAS, May 10, 2024 (GLOBE NEWSWIRE) -- Instil Bio, Inc. (“Instil”) (Nasdaq: TIL), a clinical-stage biopharmaceutical company focused on developing a pipeline of novel therapies, today reported its first quarter 2024 financial results and provided a corporate update....

Themefolio

Profiler

Peergroup

NASDAQ:TIL

*TF

Instil Bio, Inc., a clinical-stage biopharmaceutical company, develops therapies for the treatment of patients with cancer. The company develops cell therapy of autologous tumor infiltrating lymphocyte (TIL). Its TIL product candidates in pipeline include ITIL-168 for indications, such as melanoma, ...

... ...More Info

Where to trade?

26.000 tradable Securities, ETFs ...., Inform here

Field	Value
Name	Instil Bio
Ticker	TIL.OQ
ISIN	US45783C2008
WKN	A3E2GE
SYMBOL	TIL
CUSIP	45783C200
SEDOL	BM92RK9
GICS	Health Care
FIGI	BBG00ZGYN521
TV:ID	NASDAQ:TIL
IPO	19.03.2021
PEER	Healthcare
ID	3082

Interested in more information from
Instil Bio

10.05.2024

ISIN: US74039M3097

Predictive Oncology, Inc.

POAI

LISTED

NASDAQ

Predictive Oncology to Report First Quarter 2024 Financial Results on Wednesday, May 15, 2024

Artikel

News Preview

Management to host conference call and webcast at 8:30am ET Management to host conference call and webcast at 8:30am ET...

Themefolio

Profiler

Peergroup

NASDAQ:POAI

*TF

Predictive Oncology Inc., a knowledge-driven company, focuses on developing personalized cancer therapies using artificial intelligence (AI) primarily in the United States. The company operates in four segments: Helomics, zPREDICTA, Soluble, and Skyline. The Helomics segment offers clinical testing ...

... ...More Info

Where to trade?

26.000 tradable Securities, ETFs ...., Inform here

Field	Value
Name	Predictive Oncology
Ticker	POAI.OQ
ISIN	US74039M3097
WKN	A2QPFZ
SYMBOL	POAI
CUSIP	74039M309
SEDOL
GICS	Health Care
FIGI	BBG000PVXTF7
TV:ID	NASDAQ:POAI
IPO	03.05.2010
PEER	EQTY
ID	6074

Sponsor

SOMETHING BIG WILL HAPPEN

Um den Chart aufzurufen, Symbol unten rechts benutzen

Hedge · Leverage · Fractionals

Interested in more information from
Predictive Oncology

10.05.2024

ISIN: BE0003766806

Ion Beam Applications SA

IBAB

LISTED

EURONEXT

IBA : 2024 AGM - Convening Notice

Artikel

News Preview

Cher Actionnaire,...

Themefolio

Profiler

Peergroup

EURONEXT:IBAB

*TF

Ion Beam Applications SA develops, manufactures, and supports medical devices and software solutions for cancer treatments in Belgium, the United States, and internationally. The company operates through Proton Therapy and Other Accelerators, and Dosimetry segments. The Proton Therapy and Other Acce...

... ...More Info

Where to trade?

26.000 tradable Securities, ETFs ...., Inform here

Field	Value
Name	Ion Beam
Ticker	IBAB.BR
ISIN	BE0003766806
WKN	914998
SYMBOL	IBAB
CUSIP	B5317W146
SEDOL	5705496
GICS	Health Care
FIGI	BBG000BCXPJ8
TV:ID	EURONEXT:IBAB
IPO	01.03.2000
PEER	EQTY
ID	10121

Interested in more information from
Ion Beam

09.05.2024

ISIN: US0327241065

AnaptysBio Inc

ANAB

LISTED

NASDAQ

Anaptys Announces First Quarter 2024 Financial Results and Provides Business Update

Artikel

News Preview

SAN DIEGO, May 09, 2024 (GLOBE NEWSWIRE) -- AnaptysBio, Inc. (Nasdaq: ANAB), a clinical-stage biotechnology company focused on delivering innovative immunology therapeutics, today reported financial results for the first quarter ended March 31, 2024 and provided a business update....

Themefolio

Profiler

Peergroup

NASDAQ:ANAB

*TF

AnaptysBio, Inc., a clinical stage biotechnology company, engages in developing therapeutic product candidates for inflammation and immuno-oncology indications. Its products include Imsidolimab, an antibody that inhibits the interleukin-36 receptor (IL-36R) for the treatment of various dermatologica...

... ...More Info

Where to trade?

26.000 tradable Securities, ETFs ...., Inform here

Field	Value
Name	AnaptysBio
Ticker	ANAB.OQ
ISIN	US0327241065
WKN	A2AJ8C
SYMBOL	ANAB
CUSIP	032724106
SEDOL	BDRW1L7
GICS	Health Care
FIGI	BBG0026ZDHR0
TV:ID	NASDAQ:ANAB
IPO	26.01.2017
PEER	Healthcare
ID	963

Interested in more information from
AnaptysBio

09.05.2024

ISIN: DK0060257814

Zealand Pharma A/S

ZEAL

LISTED

CPH

Zealand Pharma conference call on May 16 at 2pm CET (8am ET) to present first quarter 2024 financial results

Artikel

News Preview

Press Release – No. 4 / 2024...

Themefolio

Profiler

Peergroup

OMXCOP:ZEAL

*TF

... ...More Info

Where to trade?

26.000 tradable Securities, ETFs ...., Inform here

Field	Value
Name	Zealand Pharma
Ticker	ZELA.CO
ISIN	DK0060257814
WKN	A0YJW7
SYMBOL	ZEAL
CUSIP	K9898X127
SEDOL	B0SDJB4
GICS	Health Care
FIGI	BBG0018JWYS7
TV:ID	OMXCOP:ZEAL
IPO	05.05.2004
PEER	EQTY
ID	10966

Interested in more information from
Zealand Pharma

09.05.2024

ISIN: ES0167733015

Oryzon Genomics SA

ORY

LISTED

BME

ORYZON to Provide Corporate Progress Updates at Several Events in May

Artikel

News Preview

MADRID, Spain and CAMBRIDGE, Mass., May 09, 2024 (GLOBE NEWSWIRE) -- Oryzon Genomics, S.A. (ISIN Code: ES0167733015, ORY), a clinical-stage biopharmaceutical company leveraging epigenetics to develop therapies in diseases with strong unmet medical need, announced today that its management will give an update on corporate progress at several inter...

Themefolio

Profiler

Peergroup

BME:ORY

*TF

Oryzon Genomics S.A., a clinical phase biopharmaceutical company, engages in the discovery and development of epigenetics-based therapeutics for patients with cancer and CNS disorders. Its clinical phase compounds include iadademstat (ORY-1001), a selective LSD1 inhibitor that is in Phase II trials ...

... ...More Info

Where to trade?

26.000 tradable Securities, ETFs ...., Inform here

Field	Value
Name	Oryzon Genomics
Ticker	ORY.MC
ISIN	ES0167733015
WKN	A2ACV2
SYMBOL	ORY
CUSIP	E7S54Q107
SEDOL	BYQDHM1
GICS	Health Care
FIGI	BBG000GMXR61
TV:ID	BME:ORY
IPO	12.04.2017
PEER	Consumer Goods - Pharmacy Products and Biotechnology
ID	8195

Interested in more information from
Oryzon Genomics

09.05.2024

ISIN: BE0974281132

Biocartis Group NV

BCART

LISTED

EURONEXT

Press release Biocartis Group NV: Biocartis Group NV provides an update regarding the publication of its annual report and the annual meeting

Artikel

News Preview

BIOCARTIS GROUP NV (Euronext Brussels: BCART) PRESS RELEASE - REGULATED INFORMATION - 09 May 2024, 07:00 CEST...

Themefolio

Profiler

Peergroup

EURONEXT:BCART

*TF

Biocartis Group NV, a molecular diagnostics company, provides diagnostic solutions enhancing clinical practice for the benefit of patients, clinicians, payers, and healthcare industry with a focus on oncology. Its proprietary molecular diagnostics Idylla platform is a real-time polymerase chain reac...

... ...More Info

Where to trade?

26.000 tradable Securities, ETFs ...., Inform here

Field	Value
Name	Biocartis
Ticker	BCART.BR
ISIN	BE0974281132
WKN	A14R82
SYMBOL	BCART
CUSIP	B1333M105
SEDOL	BWWYKX6
GICS	Health Care
FIGI	BBG008HBYKH9
TV:ID	EURONEXT:BCART
IPO	27.04.2015
PEER	EQTY
ID	9582

Interested in more information from
Biocartis

08.05.2024

ISIN: DK0060055861

Chemometec A/S

CHEMM

LISTED

CPH

Q3 2023/24 - First sale of the XM30 completed

Artikel

News Preview

ANNOUNCEMENT NO. 262...

Themefolio

Profiler

Peergroup

OMXCOP:CHEMM

*TF

... ...More Info

Where to trade?

26.000 tradable Securities, ETFs ...., Inform here

Field	Value
Name	ChemoMetec
Ticker	CHEMM.CO
ISIN	DK0060055861
WKN	A0MS80
SYMBOL	CHEMM
CUSIP	K18309102
SEDOL	B1KBGS9
GICS	Health Care
FIGI	BBG000R59D46
TV:ID	OMXCOP:CHEMM
IPO	23.01.2026
PEER	EQTY
ID	9665

Interested in more information from
ChemoMetec

08.05.2024

ISIN: DK0060336014

Novozymes A/S

NSIS B

LISTED

CPH

Trading by management and close relations of management

Artikel

News Preview

Please read the full announcement in PDF...

Themefolio

Profiler

Peergroup

OMXCOP:NSIS_B

*TF

Novozymes A/S produces and sells industrial enzymes, microorganisms, and probiotics in Europe, the Middle East, Africa, North America, the Asia Pacific, and Latin America. The company offers baking, beverages, dairy, starch, and protein solutions for the food and beverage industry; laundry, dishwash...

... ...More Info

Where to trade?

26.000 tradable Securities, ETFs ...., Inform here

Field	Value
Name	Novonesis
Ticker	NSISb.CO
ISIN	DK0060336014
WKN	A1JP9Y
SYMBOL	NSIS B
CUSIP	K7317J133
SEDOL	B798FW0
GICS	Health Care
FIGI	BBG000BLL8K7
TV:ID	OMXCOP:NSIS_B
IPO	23.01.2026
PEER	EQTY
ID	10404

Interested in more information from
Novonesis

08.05.2024

ISIN: US15102K1007

Celcuity Inc

CELC

LISTED

NASDAQ

Celcuity Inc. Schedules Release of First Quarter 2024 Financial Results and Webcast/Conference Call

Artikel

News Preview

MINNEAPOLIS, May 08, 2024 (GLOBE NEWSWIRE) -- Celcuity Inc. (Nasdaq: CELC), a clinical-stage biotechnology company pursuing development of targeted therapies for oncology, today announced that it will release its financial results for the first quarter 2024 after the market closes on Wednesday, May 15, 2024. Management will host a webcast/telecon...

Themefolio

Profiler

Peergroup

NASDAQ:CELC

*TF

Celcuity Inc., a clinical stage biotechnology company, focuses on the development of molecularly targeted therapies for cancer patients in the United States. The company's CELsignia diagnostic platform uses a patient's living tumor cells to identify the specific abnormal cellular process driving a p...

... ...More Info

Where to trade?

26.000 tradable Securities, ETFs ...., Inform here

Field	Value
Name	Celcuity
Ticker	CELC.OQ
ISIN	US15102K1007
WKN	A2JAAX
SYMBOL	CELC
CUSIP	15102K100
SEDOL	BDH6M05
GICS	Health Care
FIGI	BBG00HKBW045
TV:ID	NASDAQ:CELC
IPO	20.09.2017
PEER	Healthcare
ID	1638

Interested in more information from
Celcuity

08.05.2024

ISIN: US45258D1054

Immunocore Holdings plc

IMCR

LISTED

NASDAQ

Immunocore reports first quarter financial results and provides a business update

Artikel

News Preview

Immunocore reports first quarter financial results and provides a business update...

Themefolio

Profiler

Peergroup

NASDAQ:IMCR

*TF

Immunocore Holdings plc, a commercial-stage biotechnology company, engages in the development of immunotherapies for the treatment of cancer, infectious, and autoimmune diseases. The company offers KIMMTRAK for the treatment of patients with unresectable or metastatic uveal melanoma. Its other progr...

... ...More Info

Where to trade?

26.000 tradable Securities, ETFs ...., Inform here

Field	Value
Name	Immunocore
Ticker	IMCR.OQ
ISIN	US45258D1054
WKN	A2QNWU
SYMBOL	IMCR
CUSIP	45258D105
SEDOL	BLCD809
GICS	Health Care
FIGI	BBG00YYCXFB9
TV:ID	NASDAQ:IMCR
IPO	05.02.2021
PEER	Healthcare
ID	3016

Interested in more information from
Immunocore

08.05.2024

ISIN: DE000A1EWVY8

Formycon AG

FYB

LISTED

XETR

Formycon reports on successful operating business and financial figures for the first quarter of 2024

Artikel

News Preview

Press Release // May 8, 2024 Formycon reports on successful operating business and financial figures for the first quarter of 2024 Group revenue amounts to € 17.7 million and corresponds to plan Group EBITDA of € -5.5 million reflects investments in pipeline and corporate development Adjusted Group EBITDA of € -1.2 million shows strong at-equi......

Themefolio

Profiler

Peergroup

XETR:FYB

*TF

Formycon AG develops and markets biosimilar products. Its product pipeline includes FYB201, a biosimilar candidate for Lucentis, an ophthalmic drug used in the treatment of neovascular age-related macular degeneration and other serious eye diseases; FYB202, a biosimilar candidate for Stelara, a biop...

... ...More Info

Where to trade?

26.000 tradable Securities, ETFs ...., Inform here

Field	Value
Name	Formycon
Ticker	FYB.DE
ISIN	DE000A1EWVY8
WKN	A1EWVY
SYMBOL	FYB
CUSIP	D5651D108
SEDOL	B50LF68
GICS	Health Care
FIGI	BBG00186X810
TV:ID	XETR:FYB
IPO	29.01.2018
PEER	EQTY
ID	241

Interested in more information from
Formycon

08.05.2024

ISIN: DE000A1EWVY8

Formycon AG

FYB

LISTED

XETR

Formycon berichtet über erfolgreiches operatives Geschäft und Finanzzahlen für das erste Quartal 2024

Artikel

News Preview

Pressemitteilung // 8. Mai 2024 Formycon berichtet über erfolgreiches operatives Geschäft und Finanzzahlen für das erste Quartal 2024 Konzernumsatz beläuft sich auf 17,7 Mio. € und entspricht Planungen Konzern-EBITDA mit -5,5 Mio. € spiegelt Investitionen in die Produktpipeline und Unternehmensentwicklung wider Bereinigtes Konzern-EBITDA mit -1......

Themefolio

Profiler

Peergroup

XETR:FYB

*TF

... ...More Info

Where to trade?

26.000 tradable Securities, ETFs ...., Inform here

Field	Value
Name	Formycon
Ticker	FYB.DE
ISIN	DE000A1EWVY8
WKN	A1EWVY
SYMBOL	FYB
CUSIP	D5651D108
SEDOL	B50LF68
GICS	Health Care
FIGI	BBG00186X810
TV:ID	XETR:FYB
IPO	29.01.2018
PEER	EQTY
ID	241

Interested in more information from
Formycon

08.05.2024

ISIN: SE0002190926

Karolinska Development AB

KDEV

LISTED

STO

Karolinska Development’s portfolio company Umecrine Cognition initiates second part of clinical phase 1a/2 study in PBC

Artikel

News Preview

STOCKHOLM, SWEDEN – May 8, 2024. Karolinska Development AB (Nasdaq Stockholm: KDEV) today announces that its portfolio company Umecrine Cognition has randomized its first two patients to the second part of the ongoing clinical phase 1b/2 study of golexanolone in patients with Primary Biliary Cholangitis, PBC. Top-line results are expected in first...

Themefolio

Profiler

Peergroup

OMXSTO:KDEV

*TF

Karolinska Development AB (publ) is a venture capital firm specializing in investments in growth capital, seed stage, and early stage companies. It seeks to invest in pharmaceutical research and development, medical research, healthcare technology, gene research and development, drug delivery techno...

... ...More Info

Where to trade?

26.000 tradable Securities, ETFs ...., Inform here

Field	Value
Name	Karolinska Development
Ticker	KDEV.ST
ISIN	SE0002190926
WKN	A0M84G
SYMBOL	KDEV
CUSIP	W50064125
SEDOL	B3FPFG1
GICS	Health Care
FIGI	BBG001MKRLW7
TV:ID	OMXSTO:KDEV
IPO	15.04.2011
PEER	EQTY
ID	3239

Interested in more information from
Karolinska Development

08.05.2024

ISIN: DE0005313704

Carl Zeiss Meditec AG

AFX

LISTED

XETR

Carl Zeiss Meditec schließt das erste Halbjahr 2023/24 mit währungsbedingt leicht rückläufigem Umsatz ab

Artikel

News Preview

Carl Zeiss Meditec schließt das erste Halbjahr 2023/24 mit währungsbedingt leicht rückläufigem Umsatz ab Planmäßiger Vorratsabbau von chirurgischen Verbrauchsmaterialien im chinesischen Vertriebskanal erfolgreich beendet JENA, 8. Mai 2024 Carl Zeiss Meditec erreichte in den ersten sechs Monaten des Geschäftsjahres 2023/24 einen Umsatz von run......

Themefolio

Profiler

Peergroup

XETR:AFX

*TF

Carl Zeiss Meditec AG operates as a medical technology company in Germany, rest of Europe, the United States, Asia, and internationally. It operates in two segments, Ophthalmic Devices and Microsurgery. The Ophthalmic Devices segment offers products and solutions for the diagnosis and treatment of e...

... ...More Info

Where to trade?

26.000 tradable Securities, ETFs ...., Inform here

Field	Value
Name	Carl Zeiss Meditec
Ticker	AFXG.DE
ISIN	DE0005313704
WKN	531370
SYMBOL	AFX
CUSIP	D14895102
SEDOL	5922961
GICS	Health Care
FIGI	BBG000C7X325
TV:ID	XETR:AFX
IPO	12.04.2006
PEER	EQTY
ID	119

Interested in more information from
Carl Zeiss Meditec

08.05.2024

ISIN: DE0005313704

Carl Zeiss Meditec AG

AFX

LISTED

XETR

Carl Zeiss Meditec schließt das erste Halbjahr 2023/24 mit währungsbedingt leicht rückläufigem Umsatz ab

Artikel

News Preview

Themefolio

Profiler

Peergroup

XETR:AFX

*TF

... ...More Info

Where to trade?

26.000 tradable Securities, ETFs ...., Inform here

Field	Value
Name	Carl Zeiss Meditec
Ticker	AFXG.DE
ISIN	DE0005313704
WKN	531370
SYMBOL	AFX
CUSIP	D14895102
SEDOL	5922961
GICS	Health Care
FIGI	BBG000C7X325
TV:ID	XETR:AFX
IPO	12.04.2006
PEER	EQTY
ID	119

Interested in more information from
Carl Zeiss Meditec

08.05.2024

ISIN: DE0005313704

Carl Zeiss Meditec AG

AFX

LISTED

XETR

Carl Zeiss Meditec closes first six months 2023/24 with a slight decline in revenue due to currency effects

Artikel

News Preview

Carl Zeiss Meditec closes first six months 2023/24 with a slight decline in revenue due to currency effects Planned reduction of stocks of surgical consumables in the Chinese distribution channel successfully completed JENA, 8 May 2024 Carl Zeiss Meditec generated revenue of around €947.2m in the first six months of fiscal year 2023/24 (prior......

Themefolio

Profiler

Peergroup

XETR:AFX

*TF

... ...More Info

Where to trade?

26.000 tradable Securities, ETFs ...., Inform here

Field	Value
Name	Carl Zeiss Meditec
Ticker	AFXG.DE
ISIN	DE0005313704
WKN	531370
SYMBOL	AFX
CUSIP	D14895102
SEDOL	5922961
GICS	Health Care
FIGI	BBG000C7X325
TV:ID	XETR:AFX
IPO	12.04.2006
PEER	EQTY
ID	119

Interested in more information from
Carl Zeiss Meditec

08.05.2024

ISIN: DE0005313704

Carl Zeiss Meditec AG

AFX

LISTED

XETR

Carl Zeiss Meditec closes first six months 2023/24 with a slight decline in revenue due to currency effects

Artikel

News Preview

Themefolio

Profiler

Peergroup

XETR:AFX

*TF

... ...More Info

Where to trade?

26.000 tradable Securities, ETFs ...., Inform here

Field	Value
Name	Carl Zeiss Meditec
Ticker	AFXG.DE
ISIN	DE0005313704
WKN	531370
SYMBOL	AFX
CUSIP	D14895102
SEDOL	5922961
GICS	Health Care
FIGI	BBG000C7X325
TV:ID	XETR:AFX
IPO	12.04.2006
PEER	EQTY
ID	119

Interested in more information from
Carl Zeiss Meditec

08.05.2024

ISIN: DK0015998017

Bavarian Nordic A/S

BAVA

LISTED

CPH

Bavarian Nordic Announces Interim Results for the First Three Months of 2024

Artikel

News Preview

COPENHAGEN, Denmark, May 8, 2024 – Bavarian Nordic A/S (OMX: BAVA) announced today its interim financial results and business progress for the first three months of 2024....

Themefolio

Profiler

Peergroup

OMXCOP:BAVA

*TF

Bavarian Nordic A/S develops, manufactures, and commercializes life-saving vaccines. The company offers non-replicating smallpox and monkeypox vaccines under the IMVAMUNE, IMVANEX, and JYNNEOS names; rabies vaccine for human use under the Rabipur/RabAvert name; tick-borne encephalitis vaccine under ...

... ...More Info

Where to trade?

26.000 tradable Securities, ETFs ...., Inform here

Field	Value
Name	Bavarian Nordic
Ticker	BAVA.CO
ISIN	DK0015998017
WKN	917165
SYMBOL	BAVA
CUSIP	S55646194
SEDOL	5564619
GICS	Health Care
FIGI	BBG000D6P1V7
TV:ID	OMXCOP:BAVA
IPO	23.01.2026
PEER	EQTY
ID	9562

Interested in more information from
Bavarian Nordic

07.05.2024

ISIN: DE0005785604

Fresenius SE & Co KGaA

FRE

LISTED

XETR

Fresenius hebt Ausblick für das Geschäftsjahr 2024 an

Artikel

News Preview

Fresenius SE & Co. KGaA: Fresenius hebt Ausblick für das Geschäftsjahr 2024 an Fresenius erhöht seinen Gesamtjahres-Ausblick aufgrund des ausgezeichneten 1. Quartals sowie einer für das verbleibende Geschäftsjahr 2024 besser als ursprünglich erwarteten operativen Leistung. Fresenius erwartet nun für das Geschäftsjahr 2024 ein organisches Konz......

Themefolio

Profiler

Peergroup

XETR:FRE

*TF

Fresenius SE & Co. KGaA, a health care company, provides products and services for dialysis, hospitals, and outpatient medical care. It operates through four segments: Fresenius Medical Care, Fresenius Kabi, Fresenius Helios, and Fresenius Vamed. The Fresenius Medical Care segment offers products an...

... ...More Info

Where to trade?

26.000 tradable Securities, ETFs ...., Inform here

Field	Value
Name	Fresenius & Co
Ticker	FREG.DE
ISIN	DE0005785604
WKN	578560
SYMBOL	FRE
CUSIP	D27348263
SEDOL	4352097
GICS	Health Care
FIGI	BBG000BM8937
TV:ID	XETR:FRE
IPO	12.04.1997
PEER	EQTY
ID	247

Interested in more information from
Fresenius & Co

07.05.2024

ISIN: DE0005785604

Fresenius SE & Co KGaA

FRE

LISTED

XETR

Fresenius raises outlook for fiscal year 2024

Artikel

News Preview

Fresenius SE & Co. KGaA: Fresenius raises outlook for fiscal year 2024 Fresenius raises its full-year outlook due to the excellent first quarter and a better than originally expected operating performance for the remainder of the fiscal year 2024. Fresenius now expects organic group revenue growth between 4 and 7% for the fiscal year 2024 (pre......

Themefolio

Profiler

Peergroup

XETR:FRE

*TF

... ...More Info

Where to trade?

26.000 tradable Securities, ETFs ...., Inform here

Field	Value
Name	Fresenius & Co
Ticker	FREG.DE
ISIN	DE0005785604
WKN	578560
SYMBOL	FRE
CUSIP	D27348263
SEDOL	4352097
GICS	Health Care
FIGI	BBG000BM8937
TV:ID	XETR:FRE
IPO	12.04.1997
PEER	EQTY
ID	247

Interested in more information from
Fresenius & Co

07.05.2024

ISIN: DK0015998017

Bavarian Nordic A/S

BAVA

LISTED

CPH

Report of transactions of shares and related securities of Bavarian Nordic by persons holding managerial responsibilities and/or persons/companies closely associated with such

Artikel

News Preview

COPENHAGEN, Denmark, May 7, 2024 – Bavarian Nordic A/S (OMX: BAVA) has today received information about the following transactions of the Company’s shares/related securities by persons holding managerial responsibilities and/or persons/companies closely associated with such....

Themefolio

Profiler

Peergroup

OMXCOP:BAVA

*TF

... ...More Info

Where to trade?

26.000 tradable Securities, ETFs ...., Inform here

Field	Value
Name	Bavarian Nordic
Ticker	BAVA.CO
ISIN	DK0015998017
WKN	917165
SYMBOL	BAVA
CUSIP	S55646194
SEDOL	5564619
GICS	Health Care
FIGI	BBG000D6P1V7
TV:ID	OMXCOP:BAVA
IPO	23.01.2026
PEER	EQTY
ID	9562

Interested in more information from
Bavarian Nordic

07.05.2024

ISIN: DK0010272202

Genmab A/S

GMAB

LISTED

CPH

Capital Increase in Genmab as a Result of Employee Warrant Exercise

Artikel

News Preview

Company Announcement...

Themefolio

Profiler

Peergroup

OMXCOP:GMAB

*TF

... ...More Info

Where to trade?

26.000 tradable Securities, ETFs ...., Inform here

Field	Value
Name	Genmab
Ticker	GMAB.CO
ISIN	DK0010272202
WKN	565131
SYMBOL	GMAB
CUSIP	K3967W102
SEDOL	4595739
GICS	Health Care
FIGI	BBG000BKPC99
TV:ID	OMXCOP:GMAB
IPO	23.01.2026
PEER	EQTY
ID	9987

Interested in more information from
Genmab

07.05.2024

ISIN: US00507W2061

Actinium Pharmaceuticals Inc

ATNM

LISTED

XASE

Actinium Announces KOL Webinar to Highlight Recently Announced Iomab-ACT Trial with Leading FDA Approved Commercial CAR T-Cell Therapy Being Led by the University of Texas Southwestern

Artikel

News Preview

Dr. Farrukh Awan, Professor of Medicine, Division of Hematology Oncology at University of Texas Southwestern and Principal Investigator for the trial to join Actinium management for webinarExpansion of Iomab-ACT program with commercial CAR-T supported by ongoing MSKCC clinical trial with success implying a potential billion-dollar market opportun...

Themefolio

Profiler

Peergroup

AMEX:ATNM

*TF

... ...More Info

Where to trade?

26.000 tradable Securities, ETFs ...., Inform here

Field	Value
Name	Actinium Pharmaceuticals
Ticker	ATNM.A
ISIN	US00507W2061
WKN	A2QA48
SYMBOL	ATNM
CUSIP	00507W206
SEDOL	BLFH013
GICS	Health Care
FIGI	BBG000RQZ245
TV:ID	AMEX:ATNM
IPO	27.12.2012
PEER	Healthcare
ID	5789

Interested in more information from
Actinium Pharmaceuticals

07.05.2024

ISIN: DE000A1EWVY8

Formycon AG

FYB

LISTED

XETR

Formycon invites to the Annual General Meeting on June 12, 2024 in Munich

Artikel

News Preview

Press release // 07 May 2024 Formycon invites to the Annual General Meeting on June 12, 2024 in Munich Formycon proposes to the Annual General Meeting a more international focus and expansion of the Supervisory Board to five members With Colin Bond, Dr. Bodo Coldewey and Nicholas Haggar, three new candidates with relevant industry and financial......

Themefolio

Profiler

Peergroup

XETR:FYB

*TF

... ...More Info

Where to trade?

26.000 tradable Securities, ETFs ...., Inform here

Field	Value
Name	Formycon
Ticker	FYB.DE
ISIN	DE000A1EWVY8
WKN	A1EWVY
SYMBOL	FYB
CUSIP	D5651D108
SEDOL	B50LF68
GICS	Health Care
FIGI	BBG00186X810
TV:ID	XETR:FYB
IPO	29.01.2018
PEER	EQTY
ID	241

Interested in more information from
Formycon

07.05.2024

ISIN: DE000A1EWVY8

Formycon AG

FYB

LISTED

XETR

Formycon lädt zur ordentlichen Hauptversammlung am 12. Juni 2024 in München ein

Artikel

News Preview

Pressemitteilung // 07. Mai 2024 Formycon lädt zur ordentlichen Hauptversammlung am 12. Juni 2024 in München ein Formycon schlägt der Hauptversammlung internationalere Ausrichtung und Erweiterung des Aufsichtsrats auf fünf Mitglieder vor Mit Colin Bond, Dr. Bodo Coldewey und Nicholas Haggar stehen drei neue Kandidaten mit einschlägiger Industri......

Themefolio

Profiler

Peergroup

XETR:FYB

*TF

... ...More Info

Where to trade?

26.000 tradable Securities, ETFs ...., Inform here

Field	Value
Name	Formycon
Ticker	FYB.DE
ISIN	DE000A1EWVY8
WKN	A1EWVY
SYMBOL	FYB
CUSIP	D5651D108
SEDOL	B50LF68
GICS	Health Care
FIGI	BBG00186X810
TV:ID	XETR:FYB
IPO	29.01.2018
PEER	EQTY
ID	241

Interested in more information from
Formycon

07.05.2024

ISIN: US5588681057

Madrigal Pharmaceuticals Inc

MDGL

LISTED

NASDAQ

Madrigal Pharmaceuticals Reports First-Quarter 2024 Financial Results and Provides Corporate Updates

Artikel

News Preview

CONSHOHOCKEN, Pa., May 07, 2024 (GLOBE NEWSWIRE) -- Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL), a biopharmaceutical company focused on delivering novel therapeutics for nonalcoholic steatohepatitis (NASH), today reports first-quarter 2024 financial results and provides corporate updates....

Themefolio

Profiler

Peergroup

NASDAQ:MDGL

*TF

Madrigal Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutic candidates for the treatment of cardiovascular, metabolic, and liver diseases. Its lead product candidate is resmetirom, a liver-directed selective thyroid horm...

... ...More Info

Where to trade?

26.000 tradable Securities, ETFs ...., Inform here

Field	Value
Name	Madrigal Pharmaceuticals
Ticker	MDGL.OQ
ISIN	US5588681057
WKN	A2APCZ
SYMBOL	MDGL
CUSIP	558868105
SEDOL	BD59BS7
GICS	Health Care
FIGI	BBG000QS6NV8
TV:ID	NASDAQ:MDGL
IPO	06.02.2007
PEER	Healthcare
ID	3491

Interested in more information from
Madrigal Pharmaceuticals

07.05.2024

ISIN: DE000A1MMCC8

Medios AG

ILM1

LISTED

XETR

Medios AG records further revenue growth in the first quarter of 2024 and confirms full-year guidance

Artikel

News Preview

Press release Medios AG records further revenue growth in the first quarter of 2024 and confirms full-year guidance Revenue increases by 5.8% to €456.2 million in the first quarter Cash flow from operating activities increases to €43.4 million Closing of the Ceban acquisition planned for May 2024 Guidance 2024 confirmed: Significant incr......

Themefolio

Profiler

Peergroup

XETR:ILM1

*TF

Medios AG, together with its subsidiaries, engages in the wholesale of specialty pharmaceutical drugs in Germany. It operates through Pharmaceutical Supply and Patient-Specific Therapies segments. The Pharmaceutical Supply segment offers products on oncology, neurology, autoimmunology, ophthalmology...

... ...More Info

Where to trade?

26.000 tradable Securities, ETFs ...., Inform here

Field	Value
Name	Medios
Ticker	ILM1k.DE
ISIN	DE000A1MMCC8
WKN	A1MMCC
SYMBOL	ILM1
CUSIP	D34664124
SEDOL	B8JVC03
GICS	Health Care
FIGI	BBG000BJNVX5
TV:ID	XETR:ILM1
IPO	22.11.2016
PEER	Wholesale drugs
ID	386

Interested in more information from
Medios

07.05.2024

ISIN: DE000A1MMCC8

Medios AG

ILM1

LISTED

XETR

Medios AG verzeichnet im ersten Quartal 2024 weiteres Umsatzwachstum und bestätigt Gesamtjahresprognose

Artikel

News Preview

Pressemitteilung Medios AG verzeichnet im ersten Quartal 2024 weiteres Umsatzwachstum und bestätigt Gesamtjahresprognose Umsatzsteigerung im ersten Quartal um 5,8 % auf 456,2 Mio. € Cashflow aus betrieblicher Tätigkeit steigt auf 43,4 Mio. € Closing der Übernahme von Ceban im Mai 2024 vorgesehen Prognose 2024 bestätigt: Signifikante Steig......

Themefolio

Profiler

Peergroup

XETR:ILM1

*TF

... ...More Info

Where to trade?

26.000 tradable Securities, ETFs ...., Inform here

Field	Value
Name	Medios
Ticker	ILM1k.DE
ISIN	DE000A1MMCC8
WKN	A1MMCC
SYMBOL	ILM1
CUSIP	D34664124
SEDOL	B8JVC03
GICS	Health Care
FIGI	BBG000BJNVX5
TV:ID	XETR:ILM1
IPO	22.11.2016
PEER	Wholesale drugs
ID	386

Interested in more information from
Medios

07.05.2024

ISIN: CH0012549785

Sonova Holding AG

SOON

LISTED

SIX

Sonova announces Management Board succession

Artikel

News Preview

Sonova Holding AG / Key word(s): Personnel Sonova announces Management Board succession 07.05.2024 / 07:00 CET/CEST Media Release Stäfa (Switzerland), May 7, 2024 – Sonova Holding AG, a leading provider of hearing care solutions, today announces upcoming appointments to its Management Board. Lilika Beck, currently Manag......

Themefolio

Profiler

Peergroup

SIX:SOON

*TF

... ...More Info

Where to trade?

26.000 tradable Securities, ETFs ...., Inform here

Field	Value
Name	Sonova
Ticker	SOON.S
ISIN	CH0012549785
WKN	893484
SYMBOL	SOON
CUSIP	H8024W106
SEDOL	7156036
GICS	Health Care
FIGI	BBG000J03DM2
TV:ID	SIX:SOON
IPO	01.04.2000
PEER	EQTY
ID	8641

Interested in more information from
Sonova

07.05.2024

ISIN: CH0012549785

Sonova Holding AG

SOON

LISTED

SIX

Sonova announces Management Board succession

Artikel

News Preview

Themefolio

Profiler

Peergroup

SIX:SOON

*TF

... ...More Info

Where to trade?

26.000 tradable Securities, ETFs ...., Inform here

Field	Value
Name	Sonova
Ticker	SOON.S
ISIN	CH0012549785
WKN	893484
SYMBOL	SOON
CUSIP	H8024W106
SEDOL	7156036
GICS	Health Care
FIGI	BBG000J03DM2
TV:ID	SIX:SOON
IPO	01.04.2000
PEER	EQTY
ID	8641

Interested in more information from
Sonova

07.05.2024

ISIN: CH0012549785

Sonova Holding AG

SOON

LISTED

SIX

Sonova kündigt Nachfolge für Geschäftsleitung an

Artikel

News Preview

Sonova Holding AG / Schlagwort(e): Personalie Sonova kündigt Nachfolge für Geschäftsleitung an 07.05.2024 / 07:00 CET/CEST Medienmitteilung Stäfa (Schweiz), 7. Mai, 2024 – Sonova Holding AG, ein führender Anbieter von Hörlösungen, gibt heute bevorstehende Ernennungen in die Geschäftsleitung bekannt. Lilika Beck, aktuell......

Themefolio

Profiler

Peergroup

SIX:SOON

*TF

... ...More Info

Where to trade?

26.000 tradable Securities, ETFs ...., Inform here

Field	Value
Name	Sonova
Ticker	SOON.S
ISIN	CH0012549785
WKN	893484
SYMBOL	SOON
CUSIP	H8024W106
SEDOL	7156036
GICS	Health Care
FIGI	BBG000J03DM2
TV:ID	SIX:SOON
IPO	01.04.2000
PEER	EQTY
ID	8641

Interested in more information from
Sonova

07.05.2024

ISIN: DK0060448595

Coloplast A/S

COLO B

LISTED

CPH

Coloplast strengthens ostomy care portfolio with three significant product launches

Artikel

News Preview

The company has received reimbursement approval in the UK for Heylo™, the world’s first digital leakage notification system, and expands its SenSura® Mio ostomy range with two new products....

Themefolio

Profiler

Peergroup

OMXCOP:COLO_B

*TF

... ...More Info

Where to trade?

26.000 tradable Securities, ETFs ...., Inform here

Field	Value
Name	Coloplast
Ticker	COLOb.CO
ISIN	DK0060448595
WKN	A1KAGC
SYMBOL	COLO B
CUSIP	K16018192
SEDOL	B8FMRX8
GICS	Health Care
FIGI	BBG000BLV8Z0
TV:ID	OMXCOP:COLO_B
IPO	23.01.2026
PEER	EQTY
ID	9701

Interested in more information from
Coloplast

07.05.2024

ISIN: DK0060448595

Coloplast A/S

COLO B

LISTED

CPH

Coloplast A/S - Announcement no. 02/2024 - Interim Financial Report, H1 2023/24

Artikel

News Preview

H1 2023/24Interim financial results, H1 2023/241 October 2023 - 31 March 2024...

Themefolio

Profiler

Peergroup

OMXCOP:COLO_B

*TF

... ...More Info

Where to trade?

26.000 tradable Securities, ETFs ...., Inform here

Field	Value
Name	Coloplast
Ticker	COLOb.CO
ISIN	DK0060448595
WKN	A1KAGC
SYMBOL	COLO B
CUSIP	K16018192
SEDOL	B8FMRX8
GICS	Health Care
FIGI	BBG000BLV8Z0
TV:ID	OMXCOP:COLO_B
IPO	23.01.2026
PEER	EQTY
ID	9701

Interested in more information from
Coloplast

06.05.2024

ISIN: ES0167733015

Oryzon Genomics SA

ORY

LISTED

BME

ORYZON Reports Financial Results and Corporate Update for Quarter Ended March 31, 2024

Artikel

News Preview

MADRID, Spain and CAMBRIDGE, Mass., May 06, 2024 (GLOBE NEWSWIRE) -- Oryzon Genomics, S.A. (ISIN Code: ES0167733015, ORY), a clinical-stage biopharmaceutical company leveraging epigenetics to develop therapies in diseases with a strong unmet medical need, today reported financial results for the quarter ended March 31, 2024 and provided a corpora...

Themefolio

Profiler

Peergroup

BME:ORY

*TF

... ...More Info

Where to trade?

26.000 tradable Securities, ETFs ...., Inform here

Field	Value
Name	Oryzon Genomics
Ticker	ORY.MC
ISIN	ES0167733015
WKN	A2ACV2
SYMBOL	ORY
CUSIP	E7S54Q107
SEDOL	BYQDHM1
GICS	Health Care
FIGI	BBG000GMXR61
TV:ID	BME:ORY
IPO	12.04.2017
PEER	Consumer Goods - Pharmacy Products and Biotechnology
ID	8195

Interested in more information from
Oryzon Genomics

06.05.2024

ISIN: DE000A1MMCC8

Medios AG

ILM1

LISTED

XETR

Constantijn van Rietschoten zum Vorstand für Internationale Märkte bestellt

Artikel

News Preview

Medios AG: Constantijn van Rietschoten zum Vorstand für Internationale Märkte bestellt Berlin, 6. Mai 2024 – Der Aufsichtsrat der Medios AG („Medios“) hat Constantijn van Rietschoten mit Wirkung zum 1. Mai 2024 zum Mitglied des Vorstands der Gesellschaft bestellt. In seiner neuen Funktion als Chief International Markets wird van Rietschoten, der se......

Themefolio

Profiler

Peergroup

XETR:ILM1

*TF

... ...More Info

Where to trade?

26.000 tradable Securities, ETFs ...., Inform here

Field	Value
Name	Medios
Ticker	ILM1k.DE
ISIN	DE000A1MMCC8
WKN	A1MMCC
SYMBOL	ILM1
CUSIP	D34664124
SEDOL	B8JVC03
GICS	Health Care
FIGI	BBG000BJNVX5
TV:ID	XETR:ILM1
IPO	22.11.2016
PEER	Wholesale drugs
ID	386

Interested in more information from
Medios

06.05.2024

ISIN: DE000A1MMCC8

Medios AG

ILM1

LISTED

XETR

Constantijn van Rietschoten zum Vorstand für Internationale Märkte bestellt

Artikel

News Preview

Themefolio

Profiler

Peergroup

XETR:ILM1

*TF

... ...More Info

Where to trade?

26.000 tradable Securities, ETFs ...., Inform here

Field	Value
Name	Medios
Ticker	ILM1k.DE
ISIN	DE000A1MMCC8
WKN	A1MMCC
SYMBOL	ILM1
CUSIP	D34664124
SEDOL	B8JVC03
GICS	Health Care
FIGI	BBG000BJNVX5
TV:ID	XETR:ILM1
IPO	22.11.2016
PEER	Wholesale drugs
ID	386

Interested in more information from
Medios

06.05.2024

ISIN: DE000A1MMCC8

Medios AG

ILM1

LISTED

XETR

Constantijn van Rietschoten appointed Executive Board member for International Markets

Artikel

News Preview

Medios AG: Constantijn van Rietschoten appointed Executive Board member for International Markets Berlin, May 6, 2024 – The Supervisory Board of Medios AG ("Medios") has appointed Constantijn van Rietschoten as member to the Company's Executive Board with effect from May 1, 2024. In his new role as Chief International Markets, van Rietschoten, who ......

Themefolio

Profiler

Peergroup

XETR:ILM1

*TF

... ...More Info

Where to trade?

26.000 tradable Securities, ETFs ...., Inform here

Field	Value
Name	Medios
Ticker	ILM1k.DE
ISIN	DE000A1MMCC8
WKN	A1MMCC
SYMBOL	ILM1
CUSIP	D34664124
SEDOL	B8JVC03
GICS	Health Care
FIGI	BBG000BJNVX5
TV:ID	XETR:ILM1
IPO	22.11.2016
PEER	Wholesale drugs
ID	386

Interested in more information from
Medios

06.05.2024

ISIN: DK0010272202

Genmab A/S

GMAB

LISTED

CPH

Transactions in Connection with Share Buy-back Program

Artikel

News Preview

Company Announcement...

Themefolio

Profiler

Peergroup

OMXCOP:GMAB

*TF

... ...More Info

Where to trade?

26.000 tradable Securities, ETFs ...., Inform here

Field	Value
Name	Genmab
Ticker	GMAB.CO
ISIN	DK0010272202
WKN	565131
SYMBOL	GMAB
CUSIP	K3967W102
SEDOL	4595739
GICS	Health Care
FIGI	BBG000BKPC99
TV:ID	OMXCOP:GMAB
IPO	23.01.2026
PEER	EQTY
ID	9987

Interested in more information from
Genmab

06.05.2024

ISIN: US8793691069

Teleflex Inc

TFX

LISTED

NYSE

Teleflex Announces Quarterly Dividend

Artikel

News Preview

WAYNE, Pa., May 06, 2024 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE: TFX) announced today that its Board of Directors declared a quarterly cash dividend of thirty-four cents ($0.34) per share of common stock. The dividend is payable June 14, 2024, to shareholders of record at the close of business on May 15, 2024. Additional information abou...

Themefolio

Profiler

Peergroup

NYSE:TFX

*TF

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. It provides vascular access products that comprise Arrow branded catheters, catheter navigation and ti...

... ...More Info

Where to trade?

26.000 tradable Securities, ETFs ...., Inform here

Field	Value
Name	Teleflex
Ticker	TFX.N
ISIN	US8793691069
WKN	855853
SYMBOL	TFX
CUSIP	879369106
SEDOL	2881407
GICS	Health Care
FIGI	BBG000BV59Y6
TV:ID	NYSE:TFX
IPO	17.03.1980
PEER	Healthcare
ID	577

Interested in more information from
Teleflex

06.05.2024

ISIN: FI0009014377

Orion Oyj

ORNBV

LISTED

HEL

Orion Corporation: Managers’ transactions – Kari Jussi Aho

Artikel

News Preview

ORION CORPORATION MANAGERS’ TRANSACTIONS 6 MAY 2024 at 12.00 EEST ...

Themefolio

Profiler

Peergroup

OMXHEX:ORNBV

*TF

Orion Oyj develops, manufactures, and markets human and veterinary pharmaceuticals and active pharmaceutical ingredients (APIs) in Finland, Scandinavia, other European countries, North America, and internationally. It provides prescription drugs and self-care products, including Nubeqa for the treat...

... ...More Info

Where to trade?

26.000 tradable Securities, ETFs ...., Inform here

Field	Value
Name	Orion
Ticker	ORNBV.HE
ISIN	FI0009014377
WKN	A0J3QM
SYMBOL	ORNBV
CUSIP	X6002Y112
SEDOL	B17NY40
GICS	Health Care
FIGI	BBG000BZR2W0
TV:ID	OMXHEX:ORNBV
IPO	07.10.2004
PEER	EQTY
ID	4057

Interested in more information from
Orion

06.05.2024

ISIN: FI0009014377

Orion Oyj

ORNBV

LISTED

HEL

Orion Corporation: Managers’ transactions – Ari Lehtoranta

Artikel

News Preview

ORION CORPORATION MANAGERS’ TRANSACTIONS 6 MAY 2024 at 12.00 EEST ...

Themefolio

Profiler

Peergroup

OMXHEX:ORNBV

*TF

... ...More Info

Where to trade?

26.000 tradable Securities, ETFs ...., Inform here

Field	Value
Name	Orion
Ticker	ORNBV.HE
ISIN	FI0009014377
WKN	A0J3QM
SYMBOL	ORNBV
CUSIP	X6002Y112
SEDOL	B17NY40
GICS	Health Care
FIGI	BBG000BZR2W0
TV:ID	OMXHEX:ORNBV
IPO	07.10.2004
PEER	EQTY
ID	4057

Interested in more information from
Orion

06.05.2024

ISIN: FI0009014377

Orion Oyj

ORNBV

LISTED

HEL

Orion Corporation: Managers’ transactions – Eija Ronkainen

Artikel

News Preview

ORION CORPORATION MANAGERS’ TRANSACTIONS 6 MAY 2024 at 12.00 EEST ...

Themefolio

Profiler

Peergroup

OMXHEX:ORNBV

*TF

... ...More Info

Where to trade?

26.000 tradable Securities, ETFs ...., Inform here

Field	Value
Name	Orion
Ticker	ORNBV.HE
ISIN	FI0009014377
WKN	A0J3QM
SYMBOL	ORNBV
CUSIP	X6002Y112
SEDOL	B17NY40
GICS	Health Care
FIGI	BBG000BZR2W0
TV:ID	OMXHEX:ORNBV
IPO	07.10.2004
PEER	EQTY
ID	4057

Interested in more information from
Orion

06.05.2024

ISIN: FI0009014377

Orion Oyj

ORNBV

LISTED

HEL

Orion Corporation: Managers’ transactions – Veli-Matti Mattila

Artikel

News Preview

ORION CORPORATION MANAGERS’ TRANSACTIONS 6 MAY 2024 at 12.00 EEST ...

Themefolio

Profiler

Peergroup

OMXHEX:ORNBV

*TF

... ...More Info

Where to trade?

26.000 tradable Securities, ETFs ...., Inform here

Field	Value
Name	Orion
Ticker	ORNBV.HE
ISIN	FI0009014377
WKN	A0J3QM
SYMBOL	ORNBV
CUSIP	X6002Y112
SEDOL	B17NY40
GICS	Health Care
FIGI	BBG000BZR2W0
TV:ID	OMXHEX:ORNBV
IPO	07.10.2004
PEER	EQTY
ID	4057

Interested in more information from
Orion

06.05.2024

ISIN: FI0009014377

Orion Oyj

ORNBV

LISTED

HEL

Orion Corporation: Managers’ transactions – Henrik Stenqvist

Artikel

News Preview

ORION CORPORATION MANAGERS’ TRANSACTIONS 6 MAY 2024 at 12.00 EEST ...

Themefolio

Profiler

Peergroup

OMXHEX:ORNBV

*TF

... ...More Info

Where to trade?

26.000 tradable Securities, ETFs ...., Inform here

Field	Value
Name	Orion
Ticker	ORNBV.HE
ISIN	FI0009014377
WKN	A0J3QM
SYMBOL	ORNBV
CUSIP	X6002Y112
SEDOL	B17NY40
GICS	Health Care
FIGI	BBG000BZR2W0
TV:ID	OMXHEX:ORNBV
IPO	07.10.2004
PEER	EQTY
ID	4057

Interested in more information from
Orion

06.05.2024

ISIN: FI0009014377

Orion Oyj

ORNBV

LISTED

HEL

Orion Corporation: Managers’ transactions – Maziar Mike Doustdar

Artikel

News Preview

ORION CORPORATION MANAGERS’ TRANSACTIONS 6 MAY 2024 at 12.00 EEST ...

Themefolio

Profiler

Peergroup

OMXHEX:ORNBV

*TF

... ...More Info

Where to trade?

26.000 tradable Securities, ETFs ...., Inform here

Field	Value
Name	Orion
Ticker	ORNBV.HE
ISIN	FI0009014377
WKN	A0J3QM
SYMBOL	ORNBV
CUSIP	X6002Y112
SEDOL	B17NY40
GICS	Health Care
FIGI	BBG000BZR2W0
TV:ID	OMXHEX:ORNBV
IPO	07.10.2004
PEER	EQTY
ID	4057

Interested in more information from
Orion

06.05.2024

ISIN: FI0009014377

Orion Oyj

ORNBV

LISTED

HEL

Orion Corporation: Managers’ transactions – Hilpi Rautelin

Artikel

News Preview

ORION CORPORATION MANAGERS’ TRANSACTIONS 6 MAY 2024 at 12.00 EEST ...

Themefolio

Profiler

Peergroup

OMXHEX:ORNBV

*TF

... ...More Info

Where to trade?

26.000 tradable Securities, ETFs ...., Inform here

Field	Value
Name	Orion
Ticker	ORNBV.HE
ISIN	FI0009014377
WKN	A0J3QM
SYMBOL	ORNBV
CUSIP	X6002Y112
SEDOL	B17NY40
GICS	Health Care
FIGI	BBG000BZR2W0
TV:ID	OMXHEX:ORNBV
IPO	07.10.2004
PEER	EQTY
ID	4057

Interested in more information from
Orion

06.05.2024

ISIN: FI0009014377

Orion Oyj

ORNBV

LISTED

HEL

Orion Corporation: Managers’ transactions – Karen Lykke Sørensen

Artikel

News Preview

ORION CORPORATION MANAGERS’ TRANSACTIONS 6 MAY 2024 at 12.00 EEST ...

Themefolio

Profiler

Peergroup

OMXHEX:ORNBV

*TF

... ...More Info

Where to trade?

26.000 tradable Securities, ETFs ...., Inform here

Field	Value
Name	Orion
Ticker	ORNBV.HE
ISIN	FI0009014377
WKN	A0J3QM
SYMBOL	ORNBV
CUSIP	X6002Y112
SEDOL	B17NY40
GICS	Health Care
FIGI	BBG000BZR2W0
TV:ID	OMXHEX:ORNBV
IPO	07.10.2004
PEER	EQTY
ID	4057